These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 7970232

  • 1. Altered neurochemical and behavioral development of 10-day-old rats perinatally exposed to the kappa opioid agonist U-50,488H.
    Shieh GJ, Walters DE.
    Neurosci Lett; 1994 Jul 18; 176(1):37-40. PubMed ID: 7970232
    [Abstract] [Full Text] [Related]

  • 2. Kappa opioid mediated locomotor activity in the preweanling rat: role of pre- and postsynaptic dopamine receptors.
    McDougall SA, Garmsen GM, Meier TL, Crawford CA.
    Psychopharmacology (Berl); 1997 Sep 18; 133(1):62-8. PubMed ID: 9335082
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site.
    Gong W, Neill DB, Lynn M, Justice JB.
    Neuroscience; 1999 Sep 18; 93(4):1349-58. PubMed ID: 10501459
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effect of chronic administration of U-50,488H, a kappa-opioid receptor agonist, on central dopamine D2 receptors of the rat.
    Veeranna, Reddy PL, Bhargava HN.
    Eur J Pharmacol; 1993 Apr 22; 235(1):23-30. PubMed ID: 8390939
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Differential modulation of the D1-like- and D2-like dopamine receptor-induced locomotor responses by group II metabotropic glutamate receptors in the rat nucleus accumbens.
    David HN, Abraini JH.
    Neuropharmacology; 2001 Sep 22; 41(4):454-63. PubMed ID: 11543765
    [Abstract] [Full Text] [Related]

  • 9. Hemispheric asymmetry in behavioral response to D1 and D2 receptor agonists in the nucleus accumbens.
    Belcheva I, Bryer JB, Starkstein SE, Honig M, Moran TH, Robinson RG.
    Brain Res; 1990 Nov 19; 533(2):286-91. PubMed ID: 1981170
    [Abstract] [Full Text] [Related]

  • 10. The group I metabotropic glutamate receptor antagonist S-4-CPG modulates the locomotor response produced by the activation of D1-like, but not D2-like, dopamine receptors in the rat nucleus accumbens.
    David HN, Abraini JH.
    Eur J Neurosci; 2001 Jun 19; 13(11):2157-64. PubMed ID: 11422457
    [Abstract] [Full Text] [Related]

  • 11. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S, Lucki I, McGonigle P.
    Brain Res; 1992 Feb 07; 571(2):313-22. PubMed ID: 1351781
    [Abstract] [Full Text] [Related]

  • 12. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR, Duncan GE, Napier TC, Bondy SC, Iorio LC, Mueller RA.
    J Pharmacol Exp Ther; 1987 Jan 07; 240(1):167-76. PubMed ID: 3100767
    [Abstract] [Full Text] [Related]

  • 13. Mechanisms of Kappa Opioid Receptor Potentiation of Dopamine D2 Receptor Function in Quinpirole-Induced Locomotor Sensitization in Rats.
    Escobar AP, González MP, Meza RC, Noches V, Henny P, Gysling K, España RA, Fuentealba JA, Andrés ME.
    Int J Neuropsychopharmacol; 2017 Aug 01; 20(8):660-669. PubMed ID: 28531297
    [Abstract] [Full Text] [Related]

  • 14. Binding characteristics of [3H]SCH 23390 in spinal cord and discrete brain regions of kappa-opiate tolerant-dependent and abstinent rats.
    Bhargava HN, Gulati A, Ramarao P.
    Pharmacology; 1991 Aug 01; 42(3):121-7. PubMed ID: 1647533
    [Abstract] [Full Text] [Related]

  • 15. The stimulation of central kappa opioid receptors decreases male sexual behavior and locomotor activity.
    Leyton M, Stewart J.
    Brain Res; 1992 Oct 23; 594(1):56-74. PubMed ID: 1334765
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of selective actions of dopamine D-1 and D-2 receptor agonists and antagonists on opioid antinociception.
    Rooney KF, Sewell RD.
    Eur J Pharmacol; 1989 Sep 22; 168(3):329-36. PubMed ID: 2573534
    [Abstract] [Full Text] [Related]

  • 17. Role of D1 and D2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats.
    Dreher JK, Jackson DM.
    Brain Res; 1989 May 22; 487(2):267-77. PubMed ID: 2525062
    [Abstract] [Full Text] [Related]

  • 18. Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum.
    Capasso A, Sorrentino L.
    Br J Pharmacol; 1997 Mar 22; 120(6):1001-6. PubMed ID: 9134209
    [Abstract] [Full Text] [Related]

  • 19. Morphine, D-Pen2, D-Pen5 enkephalin and U50,488H differentially affect the locomotor activity and behaviours induced by quinpirole in guinea-pigs.
    Brent PJ, Bot G.
    Psychopharmacology (Berl); 1992 Mar 22; 107(4):581-90. PubMed ID: 1603903
    [Abstract] [Full Text] [Related]

  • 20. Modulation of pre- and postsynaptic dopamine D2 receptor function by the selective kappa-opioid receptor agonist U69593.
    Acri JB, Thompson AC, Shippenberg T.
    Synapse; 2001 Mar 15; 39(4):343-50. PubMed ID: 11169785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.